Browse Category

NASDAQ:CNTA News 11 December 2025

Centessa Pharmaceuticals (CNTA) Stock on December 11, 2025: CEO Shake‑Up, Analyst Upgrades and 2026 Orexin Catalysts

Centessa Pharmaceuticals (CNTA) Stock on December 11, 2025: CEO Shake‑Up, Analyst Upgrades and 2026 Orexin Catalysts

Date: December 11, 2025 Centessa Pharmaceuticals plc (NASDAQ: CNTA) is back in the spotlight after a major leadership announcement and a sharp intraday pullback in its share price. On December 11, 2025, the company unveiled a CEO transition that will take effect at the start of 2026, just as its orexin program heads toward pivotal studies.GlobeNewswire+1 Shares of Centessa traded around the high‑$20s on Thursday afternoon, down meaningfully on the day following the news. Earlier in the session, financial data service GuruFocus flagged an 8.4% drop to roughly $27 per share, underscoring how sensitive the stock remains to shifts in

Stock Market Today

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

7 February 2026
AST SpaceMobile shares jumped 9.1% to $101.79 Friday after a volatile week, with 15.9 million shares traded. AT&T said it will use Amazon Leo’s satellite network to reach business customers outside its terrestrial footprint but stated this will not affect its partnership with AST. A new 2x short ETF tied to ASTS, ticker ASTN, began trading on Cboe. AST’s next “BlueBird 7” satellite launch is set for late February on Blue Origin’s New Glenn.
Go toTop